xMAP® White Papers
Getting Started with xMAP®
- xMAP® Assay Automation: Steps for Success
- xMAP® Multiplex Methods to Examine Epigenetic Modifications
- Automation of xMAP® Technology-Based Multiplex Assays
- An Alternative to Traditional Workflows for Immunogenicity Studies: xMAP® Multiplex Assays Save Time and Resources
- Accelerate Your Commercial Success: Become a Luminex Licensed Technologies Partner
- Finding the Match: 40 Antibody Resources for xMAP-based Multiplex Immunoassays
- Introducing Sheath Concentrate PLUS for xMAP® Systems
- Introducing Sheath Fluid PLUS and Drive Fluid PLUS for xMAP® Systems
- Suspension Bead Arrays: Powerful Tools for Biomarker Discovery and Validation
- Dual Reporter Functionality of the xMAP INTELLIFLEX DR-SE System
Multiplex Applications
- The Role of Proteomics in Early Cancer Detection: A Look at Six Core Benefits
- Relating Dietary Health to Accurate Quantification of the Gut Microbiome Using xMAP® Technology from the Molecular Diagnostic Company Genetic Analysis AS
- Blood-Based Biomarkers to Aid Early Detection of Alzheimer’s Disease Pathology with Luminex
- The Role of Multiplexed Assays in Vaccine Development
- The Development of HPV Vaccines and the Contributions of Luminex xMAP® Technology
- Multiplex Methods in Veterinary Medicine and Agriculture
- Multiplex Methods to Examine Epigenetic Modifications
- Measuring Antibody Binding Kinetics Using xMAP® Technology and the FLEXMAP 3D® System
- Pathogenesis of Traumatic Brain Injury
- xMAP® Multiplex Assays Enable HIV Research
- xMAP® Technology: A Benchmark for Serological Testing
- Developing a Microbiome Kit That Quantifies the Extent of Gut Microbiome Changes in Diseased Patients Using xMAP® Technology
- Potential Biomarkers of Obesity Related Inflammation for Metabolic Syndrome
- Using Luminex’s xMAP® Technology to Develop a Multiplexed Immunoassay that Quantifies Antibody Binding with G Protein-Coupled Receptors
Dialog 